ImmunoBoost: The Lymphatic Osteopathic Manipulative Treatment Protocol Study
- Conditions
- Healthy
- Registration Number
- NCT06565065
- Lead Sponsor
- Western University of Health Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria:<br><br> - Individuals must be 18 years or older.<br><br> - Individuals must provide informed consent.<br><br> - Individuals must be healthy with a BMI under 30, with no primary or secondary immune<br> deficiency or autoimmune disease/must not be immunocompromised.<br><br> - Individuals must not be using or recently have used any immune-altering medications<br> such as corticosteroids, cyclosporin, tacrolimus, and pimecrolimus<br><br> - Individuals must not have had lymphatic OMT or other physical manipulation such as<br> acupuncture, physical therapy, chiropractic, or massage therapy in the previous four<br> weeks before study enrollment.<br><br> - Individuals must have the ability to receive OMT with lymphatic techniques.<br><br> - Individuals must be able to tolerate 12 minutes of moderate physical activity.<br><br> - Individuals must not be pregnant or breastfeeding.<br><br> - Individuals must not have had a splenectomy or other spleen or oncologic surgery<br> within the past 6 months.<br><br> - Individuals must be infection-free for the past 6 weeks before starting the study<br> and have not received any immunizations within the past 6 weeks.<br><br> - Individuals must be willing to avoid strenuous activity at least 24 hours before<br> each visit.<br><br> - Individuals must be willing to abstain from moderate to intense activity in the 4<br> hours between their 2nd blood draw and their final blood draw at each of their three<br> visits.<br><br>Exclusion Criteria:<br><br> - Individuals are younger than 18 years of age.<br><br> - Individuals who do not provide informed consent.<br><br> - Individuals with a BMI over 30, or with primary or secondary immune deficiency or<br> autoimmune disease or is immunocompromised.<br><br> - Individuals using or recently have used any immune-altering medications such as<br> corticosteroids, cyclosporin, tacrolimus, and pimecrolimus<br><br> - Individuals who have had lymphatic OMT or other physical manipulation such as<br> acupuncture, physical therapy, chiropractic, or massage therapy in the previous four<br> weeks before study enrollment.<br><br> - Individuals who don't have the ability to receive OMT with lymphatic techniques.<br><br> - Individuals who cannot tolerate 12 minutes of moderate physical activity.<br><br> - Individuals who are pregnant or breastfeeding.<br><br> - Individuals who have had a splenectomy or other spleen or oncologic surgery within<br> the past 6 months.<br><br> - Individuals who have had an infection in the 6 weeks before starting the study and<br> or have received any immunizations within the past 6 weeks.<br><br> - Individuals not willing to avoid strenuous activity at least 24 hours before each<br> visit.<br><br> - Individuals not willing to abstain from moderate to intense activity in the 4 hours<br> between their 2nd blood draw and their final blood draw at each of their three<br> visits.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete Blood Count (CBC) with differential
- Secondary Outcome Measures
Name Time Method Pro-Inflammatory cytokine profiling;Evaluation of safety based on reported adverse events